The aim of this study was to investigate whether the coffee brewing method is associated with any death and cardiovascular mortality, beyond the contribution from major cardiovascular risk factors.
Methods and results
Altogether, 508,747 men and women aged 20–79 participating in Norwegian cardiovascular surveys were followed for an average of 20 years with respect to cause-specific death. The number of deaths was 46,341 for any cause, 12,621 for cardiovascular disease (CVD), 6202 for ischemic heart disease (IHD), and 2894 for stroke. The multivariate adjusted hazard ratios (HRs) for any death for men with no coffee consumption as reference were 0.85 (082–0.90) for filtered brew, 0.84 (0.79–0.89) for both brews, and 0.96 (0.91–1.01) for unfiltered brew. For women, the corresponding figures were 0.85 (0.81–0.90), 0.79 (0.73–0.85), and 0.91 (0.86–0.96) for filtered, both brews, and unfiltered brew, respectively. For CVD, the figures were 0.88 (0.81–0.96), 0.93 (0.83–1.04), and 0.97 (0.89–1.07) in men, and 0.80 (0.71–0.89), 0.72 (0.61–0.85), and 0.83 (0.74–0.93) in women. Stratification by age raised the HRs for ages ≥60 years. The HR for CVD between unfiltered brew and no coffee was 1.19 (1.00–1.41) for men and 0.98 (0.82–1.15) for women in this age group. The HRs for CVD and IHD were raised when omitting total cholesterol from the model, and most pronounced in those drinking ≥9 of unfiltered coffee, per day where they were raised by 9% for IHD mortality.
Conclusion
Unfiltered brew was associated with higher mortality than filtered brew, and filtered brew was associated with lower mortality than no coffee consumption.
NehligADavalJLDebryG.Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev1992;
17: 139–170.
2.
KleemolaPJousilahtiPPietinenP, et al.
Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med2000;
160: 3393–3400.
3.
Lopez-GarciaEvan DamRMLiTY, et al.
The relationship of coffee consumption with mortality. Ann Intern Med2008;
148: 904–914.
4.
GrobbeeDERimmEBGiovannucciE, et al.
Coffee, caffeine, and cardiovascular disease in men. N Engl J Med1990;
323: 1026–1032.
5.
WillettWCStampferMJMansonJE, et al.
Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA1996;
275; 458–462.
6.
MyersMGBasinskiA.Coffee and coronary heart disease (1992)Arch Intern Med1992;
152: 1767–1772.
7.
Lopez-GarciaEvan DamRMWillettWC, et al.
Coffee consumption and coronary heart disease in men and women. Circulation2006;
113: 2045–2053.
8.
FreedmanNDParkYAbnetCC, et al.
Association of coffee drinking with total and cause-specific mortality. N Engl J Med2012;
366; 1891–1904.
9.
MineharuYKoizumiAWadaY, et al.
Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health2011;
65: 230–240.
10.
ParkS-YFreedmanNDHaimanCA, et al.
Association of coffee consumption with total and cause-specific mortality among non-white populations. Ann Intern Med2017;
167: 228–235.
11.
LeGradyDDyerARShekelleRB, et al.
Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol1987;
126: 803–812.
12.
LaCroixAZMeadLALiangK-Y, et al.
Coffee consumption and the incidence of coronary heart disease. N Engl J Med1986;
315: 977–982.
13.
TverdalAStensvoldISolvollK, et al.
Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women.BMJ1990;
300; 566–569.
14.
KouliG-MPanagiotakosDBGeorgousopoulouEN, et al.
J-shaped relationship between habitual coffee consumption and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA study. Eur J Nutr2018;
57: 1677–1685.
15.
CrippaADiscacciatiALarssonSC, et al.
Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol2014;
180(8): 763–775.
16.
MalerbaSTuratiFGaleoneC, et al.
A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol2013;
28: 527–539.
17.
DingMBhupathirajuSNSatijaA, et al.
Long-term coffee consumption and risk of cardiovascular disease. A systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation2014;
129: 643–659.
18.
GrossoGMicekAGodosJ, et al.
Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol2016;
31: 1191–1205.
19.
SofiFContiAAGoriAM, et al.
Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metabolism Cardiovasc Dis2007;
17: 209–223.
20.
WuJ-nHoSCZhouC, et al.
Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol2009;
137: 216–225.
21.
Weusten-Van der WouwMPMEKatanMBVianiR, et al.
Identity of the cholesterol-raising factor from unfiltered coffee and its effects on liver function enzymes. J Lipid Res1994;
35: 721–733.
22.
UrgertRWeusten-van der WouwMPHovenierR, et al.
Diterpenes from coffee beans decrease serum levels of lipoprotein(a) in humans: results from four randomised controlled trials. Eur J Clin Nutr1997;
51: 431–436.
23.
BjartveitKFossOPGjervigT, et al.
The cardiovascular disease study in Norwegian counties. Background and organization.Acta Med Scand Suppl1979;
634: 1–70.
24.
StensvoldITverdalAFossOP.The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol1989;
42: 877–884.
25.
NaessOSøgaardAJArnesenE, et al.
Cohort profile: cohort of Norway (CONOR). Int J Epidemiol2008;
37: 481–458.
UrgertRKatanMB.The cholesterol-raising factor from coffee beans. J R Soc Med1996;
89: 618–623.
28.
RendónMYdos Santos ScholzMBBragagnoloN.Physical characteristics of the paper filter and low content filter coffee brews. Food Res Int2018;
108: 280–285.
29.
ScalbertAManachCMorandC, et al.
Dietary polyphenols and the prevention of diseases. Critical Rev Food Sci Nutr2005;
45: 287–306.
30.
van DamRBFeskensEJM.Coffee consumption and risk of type 2 diabetes mellitus. Lancet2002;
360: 1477–1478.
31.
CarlströmMLarssonSC.Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysisNutr Rev2018;
76: 395–417.
32.
NygårdOVollsetSERefsumH, et al.
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA1996;
274: 1526–1533.
33.
NygårdORefsumHUelandPM, et al.
Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr1997;
65: 136–143.
34.
StrandhagenEZetterbergHAiresN, et al.
The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase in plasma homocysteine: a randomized placebo controlled study. Int J Mol Med2004;
13: 811–815.
35.
GrubbenMJBoersGHBlomHJ, et al.
Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr2000;
71: 480–484.
36.
Lopez-GarciaEvan DamRMQiL, et al.
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr2006;
84: 888–893.
37.
JacobsenBKThelleDS(1987) The Tromsø Heart Study: is coffee drinking an indicator of a life-style with high risk for ischemic heart disease?Acta Med Scand1987;
222: 215–221.
38.
Stensvold I. Coffee and health. Thesis. National Health Screening Service, Oslo, 1996.
StensvoldITverdalAJacobsenBK(1996) Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ1996;
312: 544–545.
42.
RabanalKSSelmerRMIglandJ, et al.
Ethnic inequalities in acute myocardial infarction and stroke rates in Norway 1994-2009: a nationwide cohort study (CVDNOR). BMC Public Health2015;
15: 1073.
